Trials / Conditions / Mature B-cell Non-Hodgkin Lymphoma
Mature B-cell Non-Hodgkin Lymphoma
6 registered clinical trials studyying Mature B-cell Non-Hodgkin Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Chemotherapy With Rituximab for Aggressive B-NHL in Children and Adolescents NCT07168980 | Children's Cancer Group, China | Phase 2 / Phase 3 |
| Recruiting | A Study to Evaluate Glofitamab Monotherapy and Glofitamab + Chemoimmunotherapy in Pediatric and Young Adult Pa NCT05533775 | Hoffmann-La Roche | Phase 1 / Phase 2 |
| Terminated | A Trial of ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas NCT05490043 | Antengene (Hangzhou) Biologics Co., Ltd. | Phase 1 |
| Terminated | A Study ATG-101 in Patients With Metastatic/Advanced Solid Tumors and Mature B-cell Non-Hodgkin Lymphomas NCT04986865 | Antengene Biologics Limited | Phase 1 |
| Active Not Recruiting | Treatment Protocol of the NHL-BFM and the NOPHO Study Groups for Mature Aggressive B-cell Lymphoma and Leukemi NCT03206671 | University Hospital Muenster | Phase 3 |
| Active Not Recruiting | BNHL-2015 for Children or Adolescents in China NCT02405676 | Children's Cancer Group, China | Phase 2 / Phase 3 |